Skip to main content

Publications

featured publications
  • Selective Modulation of the Protease Activated Protein C Using Exosite Inhibiting Aptamers.

    Nucleic acid therapeutics

    Authors: Nasim Shahidi Hamedani, Jens Müller, Fabian Tolle, Heiko Rühl, Behnaz Pezeshkpoor, Kerstin Liphardt, Johannes Oldenburg, Günter Mayer, Bernd Pötzsch

    View this publication
  • octanate: over 20 years of clinical experience in overcoming challenges in haemophilia A treatment.

    Therapeutic advances in hematology

    Authors: Anna Klukowska, Vladimír Komrska, Vladimír Vdovin, Nadezhda Zozulya, Toshko Lissitchkov, Johannes Oldenburg, Carmen Escuriola Ettingshausen

    View this publication
  • Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Beatrice Nolan, Johnny Mahlangu, Ingrid Pabinger, Guy Young, Barbara A Konkle, Chris Barnes, Keiji Nogami, Elena Santagostino, K John Pasi, Liane Khoo, Bent Winding, Huixing Yuan, Joachim Fruebis, Dan Rudin, Johannes Oldenburg

    View this publication
  • Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case-control study.

    British journal of haematology

    Authors: Alice S van Velzen, Corien L Eckhardt, Marjolein Peters, Johannes Oldenburg, Marjon Cnossen, Ri Liesner, Massimo Morfini, Giancarlo Castaman, Simon McRae, Johanna G van der Bom, Karin Fijnvandraat

    View this publication
  • The Current Understanding of Molecular Pathogenesis of Quantitative von Willebrand Disease, Types 1 and 3.

    Hamostaseologie

    Authors: Hamideh Yadegari, Johannes Oldenburg

    View this publication
  • A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.

    Blood

    Authors: Guy Young, Ri Liesner, Tiffany Chang, Robert Sidonio, Johannes Oldenburg, Victor Jiménez-Yuste, Johnny Mahlangu, Rebecca Kruse-Jarres, Michael Wang, Marianne Uguen, Michelle Y Doral, Lilyan Y Wright, Christophe Schmitt, Gallia G Levy, Midori Shima, Maria Elisa Mancuso

    View this publication
  • Clinical manifestation of hemophilia A in the absence of mutations in the F8 gene that encodes FVIII: role of microRNAs.

    Transfusion

    Authors: Katarzyna I Jankowska, Joseph McGill, Behnaz Pezeshkpoor, Johannes Oldenburg, Chintamani D Atreya, Zuben E Sauna

    View this publication
  • Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results.

    Blood

    Authors: Amy D Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Pratima Chowdary, Hermann Eichler, Victor Jiménez-Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P Wheeler, Guy Young, Silva Zupancic-Salek, Johannes Oldenburg

    View this publication
  • The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.

    Biomolecules

    Authors: Sneha Singh, Alexis Nazabal, Senthilvelrajan Kaniyappan, Jean-Luc Pellequer, Alisa S Wolberg, Diana Imhof, Johannes Oldenburg, Arijit Biswas

    View this publication
  • Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Shariq Ahmed, Hamideh Yadegari, Arshi Naz, Arijit Biswas, Ulrich Budde, Nazish Saqlain, Samina Amanat, Shehla Tariq, Fazle Raziq, Shahtaj Masood, Anna Pavlova, Tahir Sultan Shamsi, Johannes Oldenburg

    View this publication